153 related articles for article (PubMed ID: 20962274)
1. Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo.
Slee EA; Benassi B; Goldin R; Zhong S; Ratnayaka I; Blandino G; Lu X
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19479-84. PubMed ID: 20962274
[TBL] [Abstract][Full Text] [Related]
2. Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis.
Slee EA; Lu X
Sci Rep; 2013 Oct; 3():3105. PubMed ID: 24173284
[TBL] [Abstract][Full Text] [Related]
3. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.
Hoogervorst EM; Bruins W; Zwart E; van Oostrom CT; van den Aardweg GJ; Beems RB; van den Berg J; Jacks T; van Steeg H; de Vries A
Cancer Res; 2005 May; 65(9):3610-6. PubMed ID: 15867355
[TBL] [Abstract][Full Text] [Related]
4. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
6. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
[TBL] [Abstract][Full Text] [Related]
7. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice.
Xu Y; Yang EM; Brugarolas J; Jacks T; Baltimore D
Mol Cell Biol; 1998 Jul; 18(7):4385-90. PubMed ID: 9632822
[TBL] [Abstract][Full Text] [Related]
8. Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo.
Lee MK; Tong WM; Wang ZQ; Sabapathy K
Cell Death Differ; 2011 Feb; 18(2):214-21. PubMed ID: 20671749
[TBL] [Abstract][Full Text] [Related]
9. Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.
Chao C; Herr D; Chun J; Xu Y
EMBO J; 2006 Jun; 25(11):2615-22. PubMed ID: 16757976
[TBL] [Abstract][Full Text] [Related]
10. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.
Chao C; Saito S; Kang J; Anderson CW; Appella E; Xu Y
EMBO J; 2000 Sep; 19(18):4967-75. PubMed ID: 10990460
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity.
Turenne GA; Price BD
BMC Cell Biol; 2001; 2():12. PubMed ID: 11483158
[TBL] [Abstract][Full Text] [Related]
12. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage.
Chao C; Saito S; Anderson CW; Appella E; Xu Y
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11936-41. PubMed ID: 11035798
[TBL] [Abstract][Full Text] [Related]
14. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.
Price BD; Hughes-Davies L; Park SJ
Oncogene; 1995 Jul; 11(1):73-80. PubMed ID: 7624134
[TBL] [Abstract][Full Text] [Related]
15. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
[TBL] [Abstract][Full Text] [Related]
16. Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38-p53-p21 stress signaling pathway.
Suhail TV; Singh P; Manna TK
Eur J Cell Biol; 2015 Feb; 94(2):90-100. PubMed ID: 25613365
[TBL] [Abstract][Full Text] [Related]
17. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.
Armata HL; Garlick DS; Sluss HK
Cancer Res; 2007 Dec; 67(24):11696-703. PubMed ID: 18089799
[TBL] [Abstract][Full Text] [Related]
18. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
19. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.
Wulf GM; Liou YC; Ryo A; Lee SW; Lu KP
J Biol Chem; 2002 Dec; 277(50):47976-9. PubMed ID: 12388558
[TBL] [Abstract][Full Text] [Related]
20. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
